{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:03:11Z","timestamp":1762452191891,"version":"build-2065373602"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00646-9","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:27:34Z","timestamp":1755091654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined experimental and computational investigation of vildagliptin: spectroscopy, electronic structure, MD and Docking to EGFR, VEGFR2, and HER2 anticancer targets"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1532-4430","authenticated-orcid":false,"given":"Tadeusz W.","family":"Inglot","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"646_CR1","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3390\/ijerph16152720","volume":"16","author":"K Makrilakis","year":"2019","unstructured":"Makrilakis K (2019) The role of DPP-4 inhibitors in the treatment algorithm of type 2 diabetes mellitus: when to select, what to expect. Int J Environ Res Public Health 16:2720. https:\/\/doi.org\/10.3390\/ijerph16152720","journal-title":"Int J Environ Res Public Health"},{"key":"646_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13300-011-0002-3","volume":"2","author":"C Koliaki","year":"2011","unstructured":"Koliaki C, Doupis J (2011) Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus. Diabetes Therapy 2:101\u2013121. https:\/\/doi.org\/10.1007\/s13300-011-0002-3","journal-title":"Diabetes Therapy"},{"key":"646_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","volume":"398","author":"E Brown","year":"2021","unstructured":"Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH (2021) SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet 398:262\u2013276. https:\/\/doi.org\/10.1016\/S0140-6736(21)00536-5","journal-title":"Lancet"},{"key":"646_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/dom.12833","volume":"19","author":"LM Knapen","year":"2017","unstructured":"Knapen LM, de Jong RGPJ, Driessen JHM, Keulemans YC, van Erp NP, De Bruin ML, Leufkens HGM, Croes S, de Vries F (2017) Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study. Diabetes Obes Metab 19:401\u2013411. https:\/\/doi.org\/10.1111\/dom.12833","journal-title":"Diabetes Obes Metab"},{"key":"646_CR5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMp1314078","volume":"370","author":"AG Egan","year":"2014","unstructured":"Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, Rosebraugh C (2014) Pancreatic safety of Incretin-Based Drugs \u2014 FDA and EMA assessment. N Engl J Med 370:794\u2013797. https:\/\/doi.org\/10.1056\/NEJMp1314078","journal-title":"N Engl J Med"},{"key":"646_CR6","doi-asserted-by":"publisher","first-page":"f4838","DOI":"10.1136\/bmj.f4838","volume":"347","author":"D Cohen","year":"2013","unstructured":"Cohen D (2013) European drugs agency clashes with scientists over safety of GLP-1 drugs. BMJ 347:f4838\u2013f4838. https:\/\/doi.org\/10.1136\/bmj.f4838","journal-title":"BMJ"},{"key":"646_CR7","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.2337\/db12-1686","volume":"62","author":"AE Butler","year":"2013","unstructured":"Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC (2013) Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for Glucagon-Producing neuroendocrine tumors. Diabetes 62:2595\u20132604. https:\/\/doi.org\/10.2337\/db12-1686","journal-title":"Diabetes"},{"key":"646_CR8","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.2337\/dc11-s229","volume":"34","author":"D Dicker","year":"2011","unstructured":"Dicker D (2011) DPP-4 inhibitors. Diabetes Care 34:S276\u2013S278. https:\/\/doi.org\/10.2337\/dc11-s229","journal-title":"Diabetes Care"},{"key":"646_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.anai.2011.02.012","volume":"106","author":"JS Byrd","year":"2011","unstructured":"Byrd JS, Minor DS, Elsayed R, Marshall GD (2011) DPP-4 inhibitors and angioedema: a cause for concern? Annals of allergy. Asthma Immunol 106:436\u2013438. https:\/\/doi.org\/10.1016\/j.anai.2011.02.012","journal-title":"Asthma Immunol"},{"key":"646_CR10","doi-asserted-by":"crossref","unstructured":"FDA (2015) FDA Drug Safety Communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain","DOI":"10.1007\/s40278-015-5060-2"},{"key":"646_CR11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/pds.3503","volume":"22","author":"M Tarapu\u00e9s","year":"2013","unstructured":"Tarapu\u00e9s M, Cereza G, Figueras A (2013) Association of musculoskeletal complaints and gliptin use: review of spontaneous reports. Pharmacoepidemiol Drug Saf 22:1115\u20131118. https:\/\/doi.org\/10.1002\/pds.3503","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"646_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11094-022-02606-1","volume":"56","author":"EB Polyakova","year":"2022","unstructured":"Polyakova EB, Sabirzyanov DR, Prozorova NA, Foteeva AV (2022) Physicochemical properties and methods of analysis of vildagliptin (Review). Pharm Chem J 56:110\u2013117. https:\/\/doi.org\/10.1007\/s11094-022-02606-1","journal-title":"Pharm Chem J"},{"key":"646_CR13","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.ejmech.2011.01.047","volume":"46","author":"J Liu","year":"2011","unstructured":"Liu J, Obando D, Liao V, Lifa T, Codd R (2011) The many faces of the Adamantyl group in drug design. Eur J Med Chem 46:1949\u20131963. https:\/\/doi.org\/10.1016\/j.ejmech.2011.01.047","journal-title":"Eur J Med Chem"},{"key":"646_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.56782\/pps.88","volume":"10","author":"A Lis-Cieplak","year":"2012","unstructured":"Lis-Cieplak A (2012) Pochodne adamantanu - r\u00f3\u017cnorodno\u015b\u0107 Dzia\u0142a\u0144 biologicznych. Przegl\u0105d substancji Dopuszczonych do Lecznictwa w Polsce Oraz Potencjalnych Lek\u00f3w. Prospects Pharm Sci 10:18\u201325. https:\/\/doi.org\/10.56782\/pps.88","journal-title":"Prospects Pharm Sci"},{"key":"646_CR15","doi-asserted-by":"publisher","first-page":"117592","DOI":"10.1016\/j.ejmech.2025.117592","volume":"291","author":"C Dane","year":"2025","unstructured":"Dane C, Montgomery AP, Kassiou M (2025) The Adamantane scaffold: beyond a lipophilic moiety. Eur J Med Chem 291:117592. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117592","journal-title":"Eur J Med Chem"},{"key":"646_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/molecules22020297","volume":"22","author":"A \u0160timac","year":"2017","unstructured":"\u0160timac A, \u0160ekutor M, Mlinari\u0107-Majerski K, Frkanec L, Frkanec R (2017) Adamantane in drug delivery systems and surface recognition. Molecules 22:297. https:\/\/doi.org\/10.3390\/molecules22020297","journal-title":"Molecules"},{"key":"646_CR17","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1021\/cr100264t","volume":"113","author":"L Wanka","year":"2013","unstructured":"Wanka L, Iqbal K, Schreiner PR (2013) The lipophilic bullet hits the targets: medicinal chemistry of Adamantane derivatives. Chem Rev 113:3516\u20133604. https:\/\/doi.org\/10.1021\/cr100264t","journal-title":"Chem Rev"},{"key":"646_CR18","doi-asserted-by":"publisher","unstructured":"Dane C, Cumbers GA, Allen B, Montgomery AP, Danon JJ, Kassiou M (2024) Unlocking therapeutic potential: the role of Adamantane in drug discovery. Aust J Chem 77. https:\/\/doi.org\/10.1071\/CH24075","DOI":"10.1071\/CH24075"},{"key":"646_CR19","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2174\/092986710792065027","volume":"17","author":"G Lamoureux","year":"2010","unstructured":"Lamoureux G, Artavia G (2010) Use of the Adamantane structure in medicinal chemistry. Curr Med Chem 17:2967\u20132978. https:\/\/doi.org\/10.2174\/092986710792065027","journal-title":"Curr Med Chem"},{"key":"646_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.bbrc.2020.06.123","volume":"529","author":"VM Dembitsky","year":"2020","unstructured":"Dembitsky VM, Gloriozova TA, Poroikov VV (2020) Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases. Biochem Biophys Res Commun 529:1225\u20131241. https:\/\/doi.org\/10.1016\/j.bbrc.2020.06.123","journal-title":"Biochem Biophys Res Commun"},{"key":"646_CR21","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.3390\/app14093700","volume":"14","author":"\u0141 Popio\u0142ek","year":"2024","unstructured":"Popio\u0142ek \u0141, Janas W, Hordyjewska A, Biernasiuk A (2024) Novel Adamantane derivatives: synthesis, cytotoxicity and antimicrobial properties. Appl Sci 14:3700. https:\/\/doi.org\/10.3390\/app14093700","journal-title":"Appl Sci"},{"key":"646_CR22","doi-asserted-by":"publisher","first-page":"21058","DOI":"10.1038\/s41598-022-25390-0","volume":"12","author":"ET Warda","year":"2022","unstructured":"Warda ET, El-Ashmawy MB, Habib E-SE, Abdelbaky MSM, Garcia-Granda S, Thamotharan S, El-Emam AA (2022) Synthesis and in vitro antibacterial, antifungal, anti-proliferative activities of novel adamantane-containing thiazole compounds. Sci Rep 12:21058. https:\/\/doi.org\/10.1038\/s41598-022-25390-0","journal-title":"Sci Rep"},{"key":"646_CR23","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s10989-019-09983-4","volume":"26","author":"I Stankova","year":"2020","unstructured":"Stankova I, Chuchkov K, Chayrov R, Mukova L, Galabov A, Marinkova D, Danalev D (2020) Adamantane derivatives containing thiazole moiety: synthesis, antiviral and antibacterial activity. Int J Pept Res Ther 26:1781\u20131787. https:\/\/doi.org\/10.1007\/s10989-019-09983-4","journal-title":"Int J Pept Res Ther"},{"key":"646_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1039\/D0MD00108B","volume":"11","author":"EV Suslov","year":"2020","unstructured":"Suslov EV, Mozhaytsev ES, Korchagina DV, Bormotov NI, Yarovaya OI, Volcho KP, Serova OA, Agafonov AP, Maksyutov RA, Shishkina LN, Salakhutdinov NF (2020) New chemical agents based on adamantane\u2013monoterpene conjugates against orthopoxvirus infections. RSC Med Chem 11:1185\u20131195. https:\/\/doi.org\/10.1039\/D0MD00108B","journal-title":"RSC Med Chem"},{"key":"646_CR25","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.3390\/molecules25173989","volume":"25","author":"R Chayrov","year":"2020","unstructured":"Chayrov R, Parisis NA, Chatziathanasiadou MV, Vrontaki E, Moschovou K, Melagraki G, Sbirkova-Dimitrova H, Shivachev B, Schmidtke M, Mitrev Y, Sticha M, Mavromoustakos T, Tzakos AG, Stankova I (2020) Synthetic analogues of Aminoadamantane as influenza viral inhibitors\u2014In vitro, in Silico and QSAR studies. Molecules 25:3989. https:\/\/doi.org\/10.3390\/molecules25173989","journal-title":"Molecules"},{"key":"646_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.bmcl.2018.03.026","volume":"28","author":"OM Yvette","year":"2018","unstructured":"Yvette OM, Malan SF, Taylor D, Kapp E, Joubert J (2018) Adamantane amine-linked chloroquinoline derivatives as chloroquine resistance modulating agents in plasmodium falciparum. Bioorg Med Chem Lett 28:1287\u20131291. https:\/\/doi.org\/10.1016\/j.bmcl.2018.03.026","journal-title":"Bioorg Med Chem Lett"},{"key":"646_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1021\/jm0610043","volume":"50","author":"C Singh","year":"2007","unstructured":"Singh C, Kanchan R, Sharma U, Puri SK (2007) New Adamantane-Based Spiro 1,2,4-Trioxanes orally effective against rodent and Simian malaria. J Med Chem 50:521\u2013527. https:\/\/doi.org\/10.1021\/jm0610043","journal-title":"J Med Chem"},{"key":"646_CR28","doi-asserted-by":"publisher","unstructured":"Ragshaniya A, Kumar V, Tittal RK, Lal K (2024) Nascent Pharmacological advancement in Adamantane derivatives. Arch Pharm (Weinheim) 357. https:\/\/doi.org\/10.1002\/ardp.202300595","DOI":"10.1002\/ardp.202300595"},{"key":"646_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ejmech.2018.09.070","volume":"161","author":"C Mugnaini","year":"2019","unstructured":"Mugnaini C, Rabbito A, Brizzi A, Palombi N, Petrosino S, Verde R, Di Marzo V, Ligresti A, Corelli F (2019) Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease. Eur J Med Chem 161:239\u2013251. https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.070","journal-title":"Eur J Med Chem"},{"key":"646_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejmech.2016.01.045","volume":"110","author":"H Yu","year":"2016","unstructured":"Yu H, Li Y, Ge Y, Song Z, Wang C, Huang S, Jin Y, Han X, Zhen Y, Liu K, Zhou Y, Ma X (2016) Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines. Eur J Med Chem 110:195\u2013203. https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.045","journal-title":"Eur J Med Chem"},{"key":"646_CR31","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1021\/jm800285f","volume":"51","author":"P Lorenzo","year":"2008","unstructured":"Lorenzo P, Alvarez R, Ortiz MA, Alvarez S, Piedrafita FJ, de Lera \u00c1R (2008) Inhibition of I\u03baB Kinase-\u03b2 and anticancer activities of novel chalcone Adamantyl arotinoids. J Med Chem 51:5431\u20135440. https:\/\/doi.org\/10.1021\/jm800285f","journal-title":"J Med Chem"},{"key":"646_CR32","doi-asserted-by":"publisher","first-page":"104794","DOI":"10.1016\/j.bioorg.2021.104794","volume":"110","author":"MMS Wassel","year":"2021","unstructured":"Wassel MMS, Ammar YA, Elhag Ali GAM, Belal A, Mehany ABM, Ragab A (2021) Development of Adamantane scaffold containing 1,3,4-thiadiazole derivatives: design, synthesis, anti-proliferative activity and molecular Docking study targeting EGFR. Bioorg Chem 110:104794. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104794","journal-title":"Bioorg Chem"},{"key":"646_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1871520619666181207094243","volume":"19","author":"ES Mozhaitsev","year":"2019","unstructured":"Mozhaitsev ES, Zakharenko AL, Suslov EV, Korchagina DV, Zakharova OD, Vasil\u2019eva IA, Chepanova AA, Black E, Patel J, Chand R, Reynisson J, Leung IKH, Volcho KP, Salakhutdinov NF, Lavrik OI (2019) Novel inhibitors of DNA repair enzyme TDP1 combining monoterpenoid and Adamantane fragments. Anticancer Agents Med Chem 19:463\u2013472. https:\/\/doi.org\/10.2174\/1871520619666181207094243","journal-title":"Anticancer Agents Med Chem"},{"key":"646_CR34","doi-asserted-by":"publisher","first-page":"108113","DOI":"10.1016\/j.bioorg.2024.108113","volume":"155","author":"H Hu","year":"2025","unstructured":"Hu H, Wen F, Zhen T, Zhang M, Qin J, Huang J, Chen Z, Yu M, Hu S, Fang M, Zeng J-Z (2025) Design, synthesis, and biological evaluation of N1-(2-(adamantan-1-yl)-1H-indol-5-yl)-N2-(substituent)-1,2-dicarboxamides as anticancer agents targeting Nur77-mediated Endoplasmic reticulum stress. Bioorg Chem 155:108113. https:\/\/doi.org\/10.1016\/j.bioorg.2024.108113","journal-title":"Bioorg Chem"},{"key":"646_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00044-014-1086-x","volume":"24","author":"U Kalita","year":"2015","unstructured":"Kalita U, Kaping S, Nongkynrih R, Sunn M, Boiss I, Singha LI, Vishwakarma JN (2015) Synthesis, structure elucidation, and anti-inflammatory\/anti-cancer\/anti-bacterial activities of novel (Z)-3-. Med Chem Res 24:32\u201350. adamantyl-1-aryl-prop\/but-2-en-1-ones https:\/\/doi.org\/10.1007\/s00044-014-1086-x","journal-title":"Med Chem Res"},{"key":"646_CR36","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1007\/s00044-023-03145-4","volume":"32","author":"AM Jaber","year":"2023","unstructured":"Jaber AM, Al-Mahadeen MM, Al-Qawasmeh RA, Taha MO (2023) Synthesis, anticancer evaluation and Docking studies of novel adamantanyl-1,3,4-oxadiazol hybrid compounds as Aurora-A kinase inhibitors. Med Chem Res 32:2394\u20132404. https:\/\/doi.org\/10.1007\/s00044-023-03145-4","journal-title":"Med Chem Res"},{"key":"646_CR37","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.32604\/biocell.2022.021754","volume":"46","author":"P Jaiswal","year":"2022","unstructured":"Jaiswal P, Tripathi V, Assaiya A, Kashyap D, Dubey R, Singh A, Kumar J, Chandra Jha H, Sharma R, Kumar Dixit A, Singh Parmar H (2022) Anti-cancer effects of sitagliptin, vildagliptin, and exendin-4 on triple-negative breast cancer cells via mitochondrial modulation. BIOCELL 46:2645\u20132657. https:\/\/doi.org\/10.32604\/biocell.2022.021754","journal-title":"BIOCELL"},{"key":"646_CR38","doi-asserted-by":"publisher","first-page":"118870","DOI":"10.1016\/j.lfs.2020.118870","volume":"266","author":"M Nath","year":"2021","unstructured":"Nath M, Bhattacharjee K, Choudhury Y (2021) Vildagliptin, a dipeptidyl peptidase-4 inhibitor, reduces betel-nut induced carcinogenesis in female mice. Life Sci 266:118870. https:\/\/doi.org\/10.1016\/j.lfs.2020.118870","journal-title":"Life Sci"},{"key":"646_CR39","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich AV, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, Montgomery JA Jr, Peralta JE, Ogliaro F, Bearpark MJ, Heyd JJ, Brothers EN, Kudin KN, Staroverov VN, Keith TA, Kobayashi R, Normand J, Raghavachari K, Rendell AP, Burant JC, Iyengar SS, Tomasi J, Cossi M, Millam JM, Klene M, Adamo C, Cammi R, Ochterski JW, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox DJ (2016) Gaussian 16 rev B.01"},{"key":"646_CR40","doi-asserted-by":"publisher","first-page":"9950","DOI":"10.1039\/D0CC03157G","volume":"56","author":"X Ou","year":"2020","unstructured":"Ou X, Li X, Rong H, Yu L, Lu M (2020) A general method for cultivating single crystals from melt microdroplets. Chem Commun 56:9950\u20139953. https:\/\/doi.org\/10.1039\/D0CC03157G","journal-title":"Chem Commun"},{"key":"646_CR41","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/jcc.21759","volume":"32","author":"S Grimme","year":"2011","unstructured":"Grimme S, Ehrlich S, Goerigk L (2011) Effect of the damping function in dispersion corrected density functional theory. J Comput Chem 32:1456\u20131465. https:\/\/doi.org\/10.1002\/jcc.21759","journal-title":"J Comput Chem"},{"key":"646_CR42","unstructured":"Jamr\u00f3z Michal H (2004) Vibrational Energy Distribution Analysis VEDA 4"},{"key":"646_CR43","unstructured":"Glendening ED, Reed AE, Carpenter JE, Weinhold F (1998) NBO Version 3.1"},{"key":"646_CR44","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1021\/ja00279a008","volume":"108","author":"WJ Yang Weitao, Mortier","year":"1986","unstructured":"Yang Weitao, Mortier WJ (1986) The use of global and local molecular parameters for the analysis of the gas-phase basicity of amines. J Am Chem Soc 108:5708\u20135711. https:\/\/doi.org\/10.1021\/ja00279a008","journal-title":"J Am Chem Soc"},{"key":"646_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cplett.2004.06.011","volume":"393","author":"T Yanai","year":"2004","unstructured":"Yanai T, Tew DP, Handy NC (2004) A new hybrid exchange\u2013correlation functional using the Coulomb-attenuating method (CAM-B3LYP). Chem Phys Lett 393:51\u201357. https:\/\/doi.org\/10.1016\/j.cplett.2004.06.011","journal-title":"Chem Phys Lett"},{"key":"646_CR46","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1063\/1.474659","volume":"107","author":"E Canc\u00e8s","year":"1997","unstructured":"Canc\u00e8s E, Mennucci B, Tomasi J (1997) A new integral equation formalism for the polarizable continuum model: theoretical background and applications to isotropic and anisotropic dielectrics. J Chem Phys 107:3032\u20133041. https:\/\/doi.org\/10.1063\/1.474659","journal-title":"J Chem Phys"},{"key":"646_CR47","doi-asserted-by":"publisher","first-page":"46265","DOI":"10.1074\/jbc.M207135200","volume":"277","author":"J Stamos","year":"2002","unstructured":"Stamos J, Sliwkowski MX, Eigenbrot C (2002) Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-Anilinoquinazoline inhibitor. J Biol Chem 277:46265\u201346272. https:\/\/doi.org\/10.1074\/jbc.M207135200","journal-title":"J Biol Chem"},{"key":"646_CR48","doi-asserted-by":"publisher","first-page":"18756","DOI":"10.1074\/jbc.M110.206193","volume":"286","author":"K Aertgeerts","year":"2011","unstructured":"Aertgeerts K, Skene R, Yano J, Sang B-C, Zou H, Snell G, Jennings A, Iwamoto K, Habuka N, Hirokawa A, Ishikawa T, Tanaka T, Miki H, Ohta Y, Sogabe S (2011) Structural analysis of the mechanism of Inhibition and allosteric activation of the kinase domain of HER2 protein. J Biol Chem 286:18756\u201318765. https:\/\/doi.org\/10.1074\/jbc.M110.206193","journal-title":"J Biol Chem"},{"key":"646_CR49","doi-asserted-by":"publisher","unstructured":"McTigue M, Murray BW, Chen JH, Deng Y-L, Solowiej J, Kania RS (2012) Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proceedings of the National Academy of Sciences 109:18281\u201318289. https:\/\/doi.org\/10.1073\/pnas.1207759109","DOI":"10.1073\/pnas.1207759109"},{"key":"646_CR50","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"646_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"646_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng Des Selection 8:127\u2013134. https:\/\/doi.org\/10.1093\/protein\/8.2.127","journal-title":"Protein Eng Des Selection"},{"key":"646_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"646_CR54","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang J, MacKerell AD (2013) CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem 34:2135\u20132145. https:\/\/doi.org\/10.1002\/jcc.23354","journal-title":"J Comput Chem"},{"key":"646_CR55","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1021\/acs.jcim.3c01053","volume":"63","author":"M Bugnon","year":"2023","unstructured":"Bugnon M, Goullieux M, R\u00f6hrig UF, Perez MAS, Daina A, Michielin O, Zoete V (2023) SwissParam 2023: A modern Web-Based tool for efficient small molecule parametrization. J Chem Inf Model 63:6469\u20136475. https:\/\/doi.org\/10.1021\/acs.jcim.3c01053","journal-title":"J Chem Inf Model"},{"key":"646_CR56","doi-asserted-by":"publisher","unstructured":"Palafox MA (2018) DFT computations on vibrational spectra: scaling procedures to improve the wavenumbers. Phys Sci Reviews 3. https:\/\/doi.org\/10.1515\/psr-2017-0184","DOI":"10.1515\/psr-2017-0184"},{"key":"646_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.18231\/j.jpbs.2022.016","volume":"10","author":"SS Mane","year":"2023","unstructured":"Mane SS, Khan MA (2023) Development of UV-Visible spectrophotometric method for the Estimation of vildagliptin in different medium. J Pharm Biol Sci 10:83\u201387. https:\/\/doi.org\/10.18231\/j.jpbs.2022.016","journal-title":"J Pharm Biol Sci"},{"key":"646_CR58","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.3390\/molecules26185632","volume":"26","author":"A Gumieniczek","year":"2021","unstructured":"Gumieniczek A, Berecka-Rycerz A, Fornal E, \u017by\u017cy\u0144ska-Granica B, Granica S (2021) Comprehensive insight into chemical stability of important antidiabetic drug vildagliptin using chromatography (LC-UV and UHPLC-DAD-MS) and spectroscopy (Mid-IR and NIR with PCA). Molecules 26:5632. https:\/\/doi.org\/10.3390\/molecules26185632","journal-title":"Molecules"},{"key":"646_CR59","doi-asserted-by":"publisher","first-page":"123594","DOI":"10.1016\/j.colsurfa.2019.123594","volume":"578","author":"J Bai","year":"2019","unstructured":"Bai J, Liu Z, Zhang J, Zhong F (2019) Synthesis and characterization of novel high transparency polymer films bearing adamantanol groups. Colloids Surf Physicochem Eng Asp 578:123594. https:\/\/doi.org\/10.1016\/j.colsurfa.2019.123594","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"646_CR60","doi-asserted-by":"publisher","first-page":"125907","DOI":"10.1016\/j.molliq.2024.125907","volume":"413","author":"P Jesionek","year":"2024","unstructured":"Jesionek P, Hachu\u0142a B, Tarnacka M, Jurkiewicz K, Kami\u0144ski K, Kami\u0144ska E (2024) Comparative studies on the nature and kinetics of phase transitions in plastic crystals: Hydrogen-bonded Adamantane derivatives. J Mol Liq 413:125907. https:\/\/doi.org\/10.1016\/j.molliq.2024.125907","journal-title":"J Mol Liq"},{"key":"646_CR61","doi-asserted-by":"publisher","first-page":"11977","DOI":"10.1021\/jp107496b","volume":"114","author":"JC Garcia","year":"2010","unstructured":"Garcia JC, Justo JF, Machado WVM, Assali LVC (2010) Structural, electronic, and vibrational properties of Amino-adamantane and Rimantadine isomers. J Phys Chem A 114:11977\u201311983. https:\/\/doi.org\/10.1021\/jp107496b","journal-title":"J Phys Chem A"},{"key":"646_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1039\/B818330A","volume":"11","author":"MA Spackman","year":"2009","unstructured":"Spackman MA, Jayatilaka D (2009) Hirshfeld surface analysis. CrystEngComm 11:19\u201332. https:\/\/doi.org\/10.1039\/B818330A","journal-title":"CrystEngComm"},{"key":"646_CR63","doi-asserted-by":"crossref","unstructured":"Politzer P, Murray JS (2021) Molecular electrostatic potentials: significance and applications. Chemical reactivity in confined systems. Wiley, pp 113\u2013134","DOI":"10.1002\/9781119683353.ch7"},{"key":"646_CR64","doi-asserted-by":"crossref","unstructured":"Boyd RW (2020) The nonlinear optical susceptibility. Nonlinear optics. Elsevier, pp 1\u201364","DOI":"10.1016\/B978-0-12-811002-7.00010-2"},{"key":"646_CR65","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.molstruc.2017.04.070","volume":"1143","author":"MM Al-Shehri","year":"2017","unstructured":"Al-Shehri MM, Al-Majed A-RA, Aljohar HI, El-Emam AA, Pathak SK, Sachan AK, Prasad O, Sinha L (2017) First principle study of a potential bioactive molecule with tetrahydroisoquinoline, carbothiomide and Adamantane scaffolds. J Mol Struct 1143:204\u2013216. https:\/\/doi.org\/10.1016\/j.molstruc.2017.04.070","journal-title":"J Mol Struct"},{"key":"646_CR66","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1063\/1.449486","volume":"83","author":"AE Reed","year":"1985","unstructured":"Reed AE, Weinstock RB, Weinhold F (1985) Natural population analysis. J Chem Phys 83:735\u2013746. https:\/\/doi.org\/10.1063\/1.449486","journal-title":"J Chem Phys"},{"key":"646_CR67","doi-asserted-by":"crossref","unstructured":"Fuentealba P, Cardenas C, Pino-Rios R, Tiznado W (2016) Topological Analysis of the Fukui Function. pp 227\u2013241","DOI":"10.1007\/978-3-319-29022-5_8"},{"key":"646_CR68","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10910-014-0437-7","volume":"53","author":"JI Mart\u00ednez-Araya","year":"2015","unstructured":"Mart\u00ednez-Araya JI (2015) Why is the dual descriptor a more accurate local reactivity descriptor than Fukui functions? J Math Chem 53:451\u2013465. https:\/\/doi.org\/10.1007\/s10910-014-0437-7","journal-title":"J Math Chem"},{"key":"646_CR69","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/molecules21060748","volume":"21","author":"L Domingo","year":"2016","unstructured":"Domingo L, R\u00edos-Guti\u00e9rrez M, P\u00e9rez P (2016) Applications of the conceptual density functional theory indices to organic chemistry reactivity. Molecules 21:748. https:\/\/doi.org\/10.3390\/molecules21060748","journal-title":"Molecules"},{"key":"646_CR70","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1021\/cr990029p","volume":"103","author":"P Geerlings","year":"2003","unstructured":"Geerlings P, De Proft F, Langenaeker W (2003) Conceptual density functional theory. Chem Rev 103:1793\u20131874. https:\/\/doi.org\/10.1021\/cr990029p","journal-title":"Chem Rev"},{"key":"646_CR71","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/00387010.2024.2432331","volume":"58","author":"TS Oktemer","year":"2025","unstructured":"Oktemer TS, Celik S, Ozel AE, Akyuz S, Er A (2025) Vibrational spectroscopic characterization, quantum chemical, molecular Docking and molecular dynamics investigations of cyclo(L-phenylalanyl-L-proline), an anticancer agent. Spectrosc Lett 58:241\u2013259. https:\/\/doi.org\/10.1080\/00387010.2024.2432331","journal-title":"Spectrosc Lett"},{"key":"646_CR72","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1080\/07391102.2023.2245493","volume":"42","author":"S Celik","year":"2024","unstructured":"Celik S, Yilmaz G, Akyuz S, Ozel AE (2024) Shedding light into the biological activity of aminopterin, via molecular structural, docking, and molecular dynamics analyses. J Biomol Struct Dyn 42:7773\u20137794. https:\/\/doi.org\/10.1080\/07391102.2023.2245493","journal-title":"J Biomol Struct Dyn"},{"key":"646_CR73","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/jcc.20823","volume":"29","author":"NM O\u2019boyle","year":"2008","unstructured":"O\u2019boyle NM, Tenderholt AL, Langner KM (2008) Cclib: A library for package-independent computational chemistry algorithms. J Comput Chem 29:839\u2013845. https:\/\/doi.org\/10.1002\/jcc.20823","journal-title":"J Comput Chem"},{"key":"646_CR74","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1063\/1.1558471","volume":"118","author":"RL Martin","year":"2003","unstructured":"Martin RL (2003) Natural transition orbitals. J Chem Phys 118:4775\u20134777. https:\/\/doi.org\/10.1063\/1.1558471","journal-title":"J Chem Phys"},{"key":"646_CR75","doi-asserted-by":"crossref","unstructured":"Sholl DS, Steckel JA (2009) Density functional theory. Wiley","DOI":"10.1002\/9780470447710"},{"key":"646_CR76","doi-asserted-by":"crossref","unstructured":"Kobayashi N, Muranaka A, Mack J (2011) Circular dichroism and magnetic circular dichroism spectroscopy for organic chemists. The Royal Society of Chemistry","DOI":"10.1039\/9781849732932"},{"key":"646_CR77","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1677\/erc.1.00600","volume":"11","author":"PM Harari","year":"2004","unstructured":"Harari PM (2004) Epidermal growth factor receptor Inhibition strategies in oncology. Endocr Relat Cancer 11:689\u2013708. https:\/\/doi.org\/10.1677\/erc.1.00600","journal-title":"Endocr Relat Cancer"},{"key":"646_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1517\/14728222.2011.648617","volume":"16","author":"P Seshacharyulu","year":"2012","unstructured":"Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK (2012) Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets 16:15\u201331. https:\/\/doi.org\/10.1517\/14728222.2011.648617","journal-title":"Expert Opin Ther Targets"},{"key":"646_CR79","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.3390\/ijms21207779","volume":"21","author":"F Sangande","year":"2020","unstructured":"Sangande F, Julianti E, Tjahjono DH (2020) Ligand-Based pharmacophore modeling, molecular docking, and molecular dynamic studies of dual tyrosine kinase inhibitor of EGFR and VEGFR2. Int J Mol Sci 21:7779. https:\/\/doi.org\/10.3390\/ijms21207779","journal-title":"Int J Mol Sci"},{"key":"646_CR80","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1634\/theoncologist.2008-0276","volume":"14","author":"NA Pennell","year":"2009","unstructured":"Pennell NA, Lynch TJ (2009) Combined Inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC. Oncologist 14:399\u2013411. https:\/\/doi.org\/10.1634\/theoncologist.2008-0276","journal-title":"Oncologist"},{"key":"646_CR81","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.2147\/DDDT.S111914","volume":"10","author":"MCB Tirumalasetty","year":"2016","unstructured":"Tirumalasetty MCB, Aluru R, Baki VB, Devi S, Gunasekar D, Rajendra W (2016) Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of <\u2009em\u2009>\u2009syzygium alternifolium\u2009through molecular dynamics and pharmacophore-based screening. Drug Des Devel Ther Volume 10:3611\u20133632. https:\/\/doi.org\/10.2147\/DDDT.S111914","journal-title":"Drug Des Devel Ther Volume"},{"key":"646_CR82","doi-asserted-by":"publisher","first-page":"107653","DOI":"10.1016\/j.bioorg.2024.107653","volume":"151","author":"H-N Liu","year":"2024","unstructured":"Liu H-N, Zhu Y, Chi Y, Zhang Y, Li X, Wen W, Shan L-S, Wang Y-T, Dai B (2024) Synthetic routes and clinical application of Small-Molecule HER2 inhibitors for cancer therapy. Bioorg Chem 151:107653. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107653","journal-title":"Bioorg Chem"},{"key":"646_CR83","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.3390\/molecules28227607","volume":"28","author":"H Yang","year":"2023","unstructured":"Yang H, Zhang Z, Liu Q, Yu J, Liu C, Lu W (2023) Identification of Dual-Target inhibitors for epidermal growth factor receptor and AKT: virtual screening based on structure and molecular dynamics study. Molecules 28:7607. https:\/\/doi.org\/10.3390\/molecules28227607","journal-title":"Molecules"},{"key":"646_CR84","doi-asserted-by":"publisher","first-page":"e0321500","DOI":"10.1371\/journal.pone.0321500","volume":"20","author":"MN Khan","year":"2025","unstructured":"Khan MN, Farooq U, Khushal A, Wani TA, Zargar S, Khan S (2025) Unraveling potential EGFR kinase inhibitors: computational screening, molecular dynamics insights, and MMPBSA analysis for targeted cancer therapy development. PLoS ONE 20:e0321500. https:\/\/doi.org\/10.1371\/journal.pone.0321500","journal-title":"PLoS ONE"},{"key":"646_CR85","doi-asserted-by":"publisher","first-page":"13934","DOI":"10.1038\/srep13934","volume":"5","author":"J Sun","year":"2015","unstructured":"Sun J, Wang X-Y, Lv P-C, Zhu H-L (2015) Discovery of a series of novel Phenylpiperazine derivatives as EGFR TK inhibitors. Sci Rep 5:13934. https:\/\/doi.org\/10.1038\/srep13934","journal-title":"Sci Rep"},{"key":"646_CR86","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1007\/s00044-014-1090-1","volume":"23","author":"P Singh","year":"2014","unstructured":"Singh P, Bast F (2014) In Silico molecular Docking study of natural compounds on wild and mutated epidermal growth factor receptor. Med Chem Res 23:5074\u20135085. https:\/\/doi.org\/10.1007\/s00044-014-1090-1","journal-title":"Med Chem Res"},{"key":"646_CR87","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12885-018-4050-1","volume":"18","author":"S Rampogu","year":"2018","unstructured":"Rampogu S, Baek A, Zeb A, Lee KW (2018) Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular Docking mechanism and molecular dynamics simulations. BMC Cancer 18:264. https:\/\/doi.org\/10.1186\/s12885-018-4050-1","journal-title":"BMC Cancer"},{"key":"646_CR88","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s11030-021-10304-5","volume":"26","author":"D Paul","year":"2022","unstructured":"Paul D, Mahanta S, Tag H, Das SK, Das Gupta D, Tanti B, Ananthan R, Das R, Jambhulkar S, Hui PK (2022) Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax Pseudoginseng for RTK\u2014HER2 and VEGFR2 receptors, by in Silico approach. Mol Divers 26:1933\u20131955. https:\/\/doi.org\/10.1007\/s11030-021-10304-5","journal-title":"Mol Divers"},{"key":"646_CR89","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/cimb47030193","volume":"47","author":"EJ Millan-Casarrubias","year":"2025","unstructured":"Millan-Casarrubias EJ, Garc\u00eda-Tejeda YV, Gonz\u00e1lez-De la Rosa CH, Ruiz-Maz\u00f3n L, Hern\u00e1ndez-Rodr\u00edguez YM, Cigarroa-Mayorga OE (2025) Molecular Docking and Pharmacological in Silico evaluation of camptothecin and related ligands as promising HER2-Targeted therapies for breast cancer. Curr Issues Mol Biol 47:193. https:\/\/doi.org\/10.3390\/cimb47030193","journal-title":"Curr Issues Mol Biol"},{"key":"646_CR90","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: A new tool to perform End-State free energy calculations with GROMACS. J Chem Theory Comput 17:6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645","journal-title":"J Chem Theory Comput"},{"key":"646_CR91","doi-asserted-by":"publisher","first-page":"8658","DOI":"10.1038\/s41598-025-93612-2","volume":"15","author":"JE Alvarado-Lozano","year":"2025","unstructured":"Alvarado-Lozano JE, Hern\u00e1ndez-Valencia JA, \u00c1vila-Avil\u00e9s RD, Bello M (2025) Insight into the inhibitory activity of mangiferin and Silybin against HER2 and EGFR using theoretical and experimental approaches. Sci Rep 15:8658. https:\/\/doi.org\/10.1038\/s41598-025-93612-2","journal-title":"Sci Rep"},{"key":"646_CR92","doi-asserted-by":"publisher","first-page":"111693","DOI":"10.1016\/j.ejmech.2019.111693","volume":"183","author":"NA El-Sayed","year":"2019","unstructured":"El-Sayed NA, Nour MS, Salem MA, Arafa RK (2019) New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: design, synthesis, cytotoxicity evaluation and in Silico studies. Eur J Med Chem 183:111693. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111693","journal-title":"Eur J Med Chem"},{"key":"646_CR93","doi-asserted-by":"publisher","first-page":"105019","DOI":"10.1016\/j.bioorg.2021.105019","volume":"113","author":"EZ Elrazaz","year":"2021","unstructured":"Elrazaz EZ, Serya RAT, Ismail NSM, Albohy A, Abou El Ella DA, Abouzid KAM (2021) Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations. Bioorg Chem 113:105019. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105019","journal-title":"Bioorg Chem"},{"key":"646_CR94","doi-asserted-by":"publisher","unstructured":"Shaldam MA, Almahli H, Angeli A, Badi RM, Khaleel EF, Zain-Alabdeen AI, Elsayed ZM, Elkaeed EB, Salem R, Supuran CT, Eldehna WM, Tawfik HO (2023) Discovery of sulfonamide-tethered Isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors. J Enzyme Inhib Med Chem 38. https:\/\/doi.org\/10.1080\/14756366.2023.2203389","DOI":"10.1080\/14756366.2023.2203389"},{"key":"646_CR95","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bioorg.2018.10.071","volume":"82","author":"NMY Elsayed","year":"2019","unstructured":"Elsayed NMY, Serya RAT, Tolba MF, Ahmed M, Barakat K, Abou El Ella DA, Abouzid KAM (2019) Design, synthesis, biological evaluation and dynamics simulation of Indazole derivatives with antiangiogenic and antiproliferative anticancer activity. Bioorg Chem 82:340\u2013359. https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.071","journal-title":"Bioorg Chem"},{"key":"646_CR96","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10822-019-00270-4","volume":"34","author":"M Bello","year":"2020","unstructured":"Bello M, Guadarrama-Garc\u00eda C, Rodriguez-Fonseca RA (2020) Dissecting the molecular recognition of dual lapatinib derivatives for EGFR\/HER2. J Comput Aided Mol Des 34:293\u2013303. https:\/\/doi.org\/10.1007\/s10822-019-00270-4","journal-title":"J Comput Aided Mol Des"},{"key":"646_CR97","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1080\/07391102.2020.1861982","volume":"40","author":"H Prabhavathi","year":"2022","unstructured":"Prabhavathi H, Dasegowda KR, Renukananda KH, Karunakar P, Lingaraju K, Raja Naika H (2022) Molecular Docking and dynamic simulation to identify potential phytocompound inhibitors for EGFR and HER2 as anti-breast cancer agents. J Biomol Struct Dyn 40:4713\u20134724. https:\/\/doi.org\/10.1080\/07391102.2020.1861982","journal-title":"J Biomol Struct Dyn"},{"key":"646_CR98","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1471-2105-15-261","volume":"15","author":"W Yim-im","year":"2014","unstructured":"Yim-im W, Sawatdichaikul O, Semsri S, Horata N, Mokmak W, Tongsima S, Suksamrarn A, Choowongkomon K (2014) Computational analyses of curcuminoid analogs against kinase domain of HER2. BMC Bioinformatics 15:261. https:\/\/doi.org\/10.1186\/1471-2105-15-261","journal-title":"BMC Bioinformatics"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00646-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00646-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00646-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:56:58Z","timestamp":1762451818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00646-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00646-9","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"66"}}